NRG1 and Alzheimer disease: AD is critically associated with age as a risk factor, and the expression of neurotrophic factors is known to decrease with increasing age.51 Collectively, our results suggest that NRG1 ameliorates cognitive dysfunction in AD through several mechanisms and that NRG1 could be developed as a therapeutic treatment for this disease.